North Rock Partners, LLC Atri Cure, Inc. Transaction History

North Rock Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$35.1 - $66.01 $124,815 - $234,731	-3,556 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$57.43 - $71.39 $1,148 - $1,427	20 Added 0.57%	3,556 $234,000
Q3 2021 Nov 12, 2021	BUY	$69.28 - $84.46 $2,979 - $3,631	43 Added 1.23%	3,536 $246,000
Q2 2021 Aug 12, 2021	SELL	$64.13 - $80.18 $1,603 - $2,004	-25 Reduced 0.71%	3,493 $277,000
Q1 2021 May 11, 2021	BUY	$53.79 - $66.98 $189,233 - $235,635	3,518 New	3,518 $230,000
Q1 2019 May 14, 2019	SELL	$26.38 - $33.34 $349,798 - $442,088	-13,260 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$26.66 - $34.85 $353,511 - $462,111	13,260 New	13,260 $406,000

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.43B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on North Rock Partners, LLC with notifications on news.